CANCER OF THE URINARY TRACT
Case Histories include Cancer of the Bladder
Between 57 and 90 out of every 100 patients with cancer of the bladder who do not choose Laetrile but choose orthodox treatment instead will be dead within five years(1). Orthodox treatment has many serious and painful side effects. It is important to consider these facts while reading the following Laetrile case histories.
E148M: Cancer of the Bladder, Previous Cancer of the Cervix
Mrs. E. was forty-eight years old in September, 1972, when she was diagnosed as having "poorly differentiated invasive endocervical carcinoma." Uterine curettings revealed adenocanthoma. Bilateral inguinal node biopsies, September 15, 1972, were negative.
An examination of the cervix revealed it to be hard and irregular and largely replaced by necrotic tumor. The radiologist stated, "1 think there is medial parametrial involvement." (‘This means he thought the cancer had also gone into the tissue and smooth muscle around the uterus.)
In a letter dated September 22, 1972, the patient’s physician—the radiologist from St. Joseph’s Hospital in Stockton, California, explained:
(1)Clinical Oncology for Medical Students and Physicians, op. cit., p. 202.
I plan 3500 rads whole pelvis radiation. I may possibly give an additional 500 rads to the left parametrial area. This will then probably be followed by 5000 to 5500 mg hours in two separate radium application.
She understands that complications may occur in spite of precautions. I also told her that chances were reasonably good, but that a cure could in no way be guaranteed. She understands these issues quite well I think.
The patient was treated with cobalt60 and radium implant therapy from September through December, 1972, for her Stage II cervical cancer.
Two years later, July, 1974, the patient was referred by her gynecologist to a urologist in Stockton, California, because of blood in her urine.
The bladder had a lesion which, in the opinion of the urologist was cancer. No treatment was recommended according to the patient—perhaps because of the extensive radiation the area had already received. The patient states she was given a few months, at most, to live.
Mrs. E., a widow and a grandmother, was "putting her affairs in order" when a salesman came to her door with a multi-volume children’s Bible set. The patient was impressed with the series and wanted to purchase it for her grandchildren. She explained to the salesman she could not purchase the Bibles despite her wish to do so because there was very little chance she would be alive long enough to complete the time payments.
Mrs. E. told the salesman that she was dying of cancer. He asked her if she had heard of Laetrile, and when the patient said no, the salesman left and returned several hours later with books on Laetrile for Mrs. E. to read.
The material she read, combined with the hopelessness of her situation under orthodox therapy, led Mrs. E. to make an appointment at the Richardson Clinic and begin a course of metabolic therapy including Laetrile on August 7, 1974.
The patient responded beautifully, as is evidenced by the comments of her urologist in a letter to the Richardson Clinic dated November 19, 1975, (sixteen months after she had been pronounced terminal). The letter reads in part as follows:
I saw Mrs. B. initially in referral from her gynecologist on July 15, 1974. concerning bladder irritative symptoms and gross hematuria of several days duration.
Office cystourethroscopy [visualizing the inside of the bladder by instrument] on July 22, 1974, disclosed a fungating bleeding posterior urinary bladder floor lesion that had all the appearances of tumor extension, while she had a low capacity urinary bladder undoubtedly associated with some delayed radiation cystitis.
The lesion had the appearance of neoplasm in my sixteen years of experience. Mrs. B. returned on November 12, 1974, requesting repeat cystoscopy and at that time, the patient was having gross hematuria (blood in the urine) with a few clots each morning and had been receiving medication from you [Richardson Clinic] for approximately three months...
Mrs. B. returned on November 17, 1975, with a "tugging" type of discomfort in her mid-pelvic region. She had had no gross hematuria for approximately one year. Repeat cystourethroscopy showed no urinary bladder floor lesions at this time, although there was a whitish area where the original lesion had been and one could see the definite outline of same. It appeared to represent some type of smooth and glistening scar tissue. Repeat pelvic examination again demonstrated definite tenderness and even more vaginal stenosis [due to previous radiation]. A bimanual rectal examination failed to disclose exidence of masses beyond the area of the cervix and urinary bladder floor.... Needless to say, I was most happy with Mrs. E.’s current situation and wished her the best of luck.
B104G: Recurrent Cancer of the Bladder
This man was sixty-three years old at the time he first sought medical treatment for blood in his urine. In October, 1974, he was X-rayed, cystoscoped (viewing of the bladder), and the tumors in his bladder were removed. The pathology report identified the tissue as "papillary type transitional cell carcinoma of the bladder, grade I to II." The surgery report states approximately 8-10 gm. of tissue was removed.
Three weeks later, surgery was performed, and additional cancerous tumor was removed. The patient, an investment counselor who lives near St. Louis, Missouri, was strongly urged to have his bladder removed. He was unwilling to submit to this surgery, so radiation was scheduled.
He received 6500 rads of cobalt during a fifty-seven-day period between November 26, 1974, and January 15, 1975. During this time the patient described himself as weak, listless, subjected to intense abdominal cramping, and as passing cloned and fresh blood in his urine. Also, during this same period he had to be hospitalized because of acute urinary retention.
May, 1975, four months after the completion of radiation treatments, surgery was again required to remove more cancerous tumor.
In November, 1975, for the second time since the radiation therapy, it was necessary to remove additional cancerous tumors. At this point, the patient stated, "The doctor concluded at this time that I should be examined every ninety days. To me, this Was an ominous sign, and I decided on vitamin therapy without further delay."
Mr. B. began metabolic therapy including Laetrile on January 15, 1976. He stated he has been conscientious about taking all the vitamins and has adhered strictly to the vegetarian diet. This is not an easy regimen for an individual who must eat frequently away from home.
Mr. B. was examined again by his local doctor on March 15, 1976, and the patient stated that three small clusters of grade II carcinoma were found. Eight months later he was examined again and advised that the cancer was no longer progressing.
It is important to restate the fact that, during the eleven months of "orthodox" therapy, five hospitalizations were required plus fifty-seven days of the out-patient treatment for cobalt therapy. Two of the surgeries were subsequent to the cobalt treatment.
During the twelve months of maintenance therapy on Laetrile, his only other medical expenses were for two cystoscopic exams from his local doctor(1)
In a letter to the Richardson Clinic dated January 5, 1977 (one year following the beginning of metabolic therapy), Mr. B. concluded:
I have been under your treatment and have followed your recommended diet for a year and, quite frankly, I have never felt better nor bad more energy. I submitted to cystoscopic examination in late November, 1976, and there was no apparent cancer progress. I was discharged from the hospital in record time.
I expect to continue your recommended treatment and diet for the remainder of my life, and we pray that nothing may happen to impede you in your work..
(1) The medical bills were vastly different under the two modalities (consensus medicine vs. metabolic therapy). Are there any insurance companies out there which would care to join our crusade for metabolic therapy?
H143E: Cancer of the Bladder
This man was fifty-eight years old when he first began to develop cancerous bladder tumors in 1971.
(He had a previous history of squamous cell carcinoma of the lip. It was resected in 1965.)
In August, 1971, Mr. H. began to pass blood in his urine. Subsequent examination revealed cancer of the bladder "Grade IV, Stage A transitional cell carcinoma." The tumors were removed, along with part of the bladder.
His symptoms returned a year later. Admission history from St. Mary’s Hospital in Reno, Nevada, dated June 22, 1973, states in part:
The patient was seen initially by me in August, 1972, with gross hematuria [blood m the urine].... The patient was scoped by me and was noted to have recurrence of tumor. This was resected. The pathology showed transition cell CA [cancer] Grade III to IV in multiple sites. He was brought back for one more resection, again Grade III CA... in addition... a prostate resection.... September, 1972, patient was noted to have microscopic foci of well differentiated adenocarcinoma. . . The patient completed his radiotherapy [5,400 rads] around February of this year .
The fourth bladder surgery was performed on lime 26, 1973 (four months following radiation). Multiple bladder biopsies were taken and then the two areas of cancer were fulgurated (burning of tissue by means of high frequency electric sparks). Pathology report stated the tissue received was "transitional carcinoma (cancer), Grade II."
November 19, 1973, the patient’s bladder was again examined. Two areas of tumor were found. The patient’s records from the Nevada hospital do not state what specifically was done about the tumors identified in November, 1973.
The patient again developed blood in the urine late in 1974. He states that the doctor advised him he could not receive any more radiation because he had already received the maximum allowable.
Apparently, the only thing that was done for the patient was to put him on Percodan for the pain. There was some question of inguinal gland involvement in cancer, and the patient also developed pain in his right hip. Lymphangiograms done at the time were inconclusive because of previous radiation to the area.
This man concluded that he had exhausted all possibilities with conventional therapy, so he turned to metabolic therapy including Laetrile. This was begun January 16, 1975.
Within two weeks he was no longer requiring the pain-killer Percodan, and instead of regularly passing large red clots of blood in his urine he was passing only occasional tiny clots, which he states were the size of a "match head".
The patient has continued on his maintenance dose of vitamins and, at the time of this report, was essentially symptom-free. This represents a two-year absence of bladder problems while on Laetrile. (A previous two-year period between August, 1971, and August, 1973, required four surgeries and 5,400 rads of radiation—at the conclusion of which the patient still had tumors of the bladder, blood in his urine, and the need for the pain-killer Percodan.)
A141JA: Cancer of the Bladder
This man was sixty-four years old at the time he went to his local doctor in October of 1974 because of discomfort in the area of the bladder. Physical examination revealed an enlarged prostate.
On October 21, 1974, the surgeon performed a transurethral removal of the prostate gland and a bladder tumor. Post-operative diagnosis was papillary carcinoma (cancer) of the urinary bladder and benign prostate hypertrophy (non-cancerous enlargement of the prostate gland).
Cystoscopic examination of the bladder was performed on February 18, 1975, and June 17, 1975. The physician’s summary stated:
The first tumor was posterior to the original resected area, and another small area was noted anteriorly at the bladder neck. These tumors had increased in size from February 18 to June 17 of this year.
Because this man had experienced a return of tumors following removal of the first cancer, he decided to seek metabolic treatment as an alternative to further surgery. He began metabolic therapy on July 22, 1975. Our last contact with this patient was in January, 1977, one and one-half years later. At that time he was maintaining his therapeutic program, was symptom-free, and it appeared his cancer was controlled.
C134CR: Cancer of the Bladder
This seventy-two-year-old woman has an extensive history of surgeries, most of which have been for cancer.
1). 1948—Removal of the uterus and ovaries, reason not dear to patient. Records not available.
2). 1959—Removal of left breast for cancer.
3). 1967—Bladder surgery: Polyp removal.
4). 1968—Colon surgery: Thirteen inches of malignant colon removed. Was told she might have five more years to live.
5). 1971—Bladder surgery.
6). 1973—Bladder surgery: Patient was told next surgery would require its removal.
7). June, 1975—Bladder surgery to repair damage from previous examination. Malignancy found. Patient was told it was inoperable. Radiation and chemotherapy were urged by the doctor. Both were refused by the patient.
Mrs. C., who is a practicing lawyer, reflected on her medical problems in this way.
I felt whipped down by these continual operations, and wondered why, with all the expenditure of money for investigation, no cause of, or remedy for, cancer had ever been found. It seemed to me that the doctors were only removing symptoms; no one had any suggestions as to why the cancer continued to recur.
The patient states she heard about vitamin therapy through friends in Oakland, who suggested she contact Dr. Richardson. Vitamin therapy was begun in March of 1975. It will be noted that this was two months before the last discovery of cancer. That does not invalidate the case, however, for it took more than two months for that bladder cancer to develop, and the usual pattern for regression of any cancer (that is to say the lump itself) in the experience of this clinic, is that the regression is steady but slow. It should be emphasized, however, that the concern of the clinic is not the lump but the total physiological milieu of the patient. This is in stark contrast to the lump-oriented thinking of orthodoxy, which says it does not matter much how the patient looks or feels as long as something is done about the lump.
Mrs. C. had been on metabolic therapy for a year at the time of our last contact with her. She stated her life has "entirely changed." She has discussed the use of metabolic therapy with her local doctor, who continues to remain noncommittal. She stays on the diet faithfully, with the exception of variations necessary because she also has hypoglycemia. She continues to take the suggested supplements.
In a letter postmarked March 28, 1976, the patient commented on the impact of vitamin therapy and on the quality of her life in these words:
There has been no need for further operations; I feel better than I did at the age of forty and I’m now seventy-two. I am a retired lawyer who now serves on numerous public and church commissions and committees; I do gardening on an acre and a quarter of lovely garden and orchard; I am an organist in a Rescue Mission Chapel; I travel extensively, and still give legal aid when called upon by clients or the local bar association.